Natco Pharma Limited, a active public limited company, was established on 19 September 1981 in Hyderabad, Telangana, India. Engaging in fertilizers & soil enhancers within the manufacturing sector, it holds CIN: L24230TG1981PLC003201. Registered under ROC Roc Hyderabad. it is listed on BSE: 524816 and NSE: NATCOPHARM. It has an authorized capital of ₹45.00 Cr and a paid-up capital of ₹35.82 Cr.
Formerly known as Natco Fine Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹3,673.60 Cr and a net worth of ₹5,592.32 Cr. Employing 4,652 professional, Its leadership includes Lakshminarayana Bolisetty (Director), Rajeev Nannapaneni (Whole-Time Director), Vijayabhaskar Dronadula (Director). Past directors included Sreerama Murthy Gubbala, Bhim Sain Bajaj, Kali Satya Bhujanga Rao Adibhatla. It holds ₹1,120.00 Cr open charges and ₹1,277.71 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Natco House , Road No.2, Banjara Hills, Hyderabad, Telangana, 500034.
L24230TG1981PLC003201
003201
19 September 1981
₹45.00 Cr
₹35.82 Cr
Roc Hyderabad
Listed (BSE: 524816, NSE: NATCOPHARM)
Active
Explore comprehensive insights into Natco Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshminarayana Bolisetty | Director | 12 Aug 2024 | Current |
| Rajeev Nannapaneni | Whole-Time Director | 01 Jun 2012 | Current |
| Vijayabhaskar Dronadula | Director | 01 Apr 2024 | Current |
| Nitin Rameshwar Jain | Director | 12 Aug 2024 | Current |
| Potluri Prasad Sivaramakrishna | Whole-Time Director | 12 Nov 2014 | Current |
| Venkaiah Chowdary Nannapaneni | Managing Director | 01 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2024 | Past |
| Pramod Abcsdd | Director | 07 Aug 2017 | Past |
| Pramod Abcsdd | Whole-Time Director | 07 Aug 2017 | Past |
| Pramod Abcsdd | Alternate Director | 12 Aug 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Nominee Director | 18 Apr 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Natco Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 50.77% increase. The company also saw a substantial improvement in profitability, with a 105.09% increase in profit. The company's net worth Soared by an impressive increase of 18.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Natco Pharma had a promoter holding of 49.71% and a public holding of 50.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,200,000,000.00
₹12,777,129,822.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2025 | State Bank Of India | ₹600.00 Cr | Open |
| 08 Mar 2011 | Others | ₹520.00 Cr | Open |
| 18 Oct 2016 | Others | ₹50.00 Cr | Satisfied |
| 22 Jun 2015 | Citi Bank N.A. | ₹12.05 Cr | Satisfied |
| 22 Dec 2014 | Citi Bank N.A. | ₹60.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Natco Pharma has a workforce of 4652 employees as of Aug 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Natco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with State Bank Of India amounted to Rs. 600.00 Cr with Charge ID 101136057 was registered on 18 Jul 2025. was recorded as a recent event.
Progress on Natco Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Lakshminarayana Bolisetty was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Progress on Nitin Rameshwar Jain was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
The activity Kantipudi Suma was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
Progress on Vijayabhaskar Dronadula was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
The CIN of Natco Pharma Limited is L24230TG1981PLC003201.
Natco Pharma Limited is headquartered at Natco House , Road No.2, Banjara Hills, Hyderabad, Telangana, 500034.
Natco Pharma Limited was incorporated on 19 September 1981.
The current directors of Natco Pharma Limited are
The primary industry of Natco Pharma Limited is Manufacturing.
Natco Pharma Limited is listed. It is listed on BSE: 524816 and NSE: NATCOPHARM.
The authorized capital of Natco Pharma Limited is ₹45.00 Cr, and the paid-up capital is ₹35.82 Cr.
The compliance status of Natco Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX